Alpha Crest Capital Management LLC Karyopharm Therapeutics Inc. Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$8.11 - $11.11 $210,859 - $288,860
-26,000 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$9.85 - $17.69 $89,635 - $160,979
9,100 Added 53.85%
26,000 $274,000
Q4 2020

Feb 12, 2021
SELL
$14.15 - $17.19 $46,695 - $56,727
-3,300 Reduced 16.34%
16,900 $262,000
Q3 2020

Nov 12, 2020
BUY
$14.14 - $19.71 $285,628 - $398,142
20,200 New
20,200 $295,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email